MINNEAPOLIS--(BUSINESS WIRE)--Following an unprecedented year of advances in the field of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), will showcase at the international VEITHsymposium™ its recently-expanded portfolio and robust pipeline of stent grafts and delivery systems, including:
